Skip to main content

Exclusive: Honey Health CEO discusses the company's $7.8M funding round

Matt Faustman, Honey Health's founder and CEO, said that in 2026 organizations will be looking for an operational platform instead of narrow point solutions.
By Anthony Vecchione , Anthony Vecchione
People working in a medical office

    Photo: Alvarez/Getty Images

AI back office platform Honey Health raised $7.8 million in seed funding led by Pelion Ventures, with participation from Streamlined, Burst Capital and 8-Bit Capital. 

The company's AI agents automate workflows, including data fetching, patient notes and charts, post-visit orders and refills, faxes and prior authorizations. 

Matt Faustman, Honey Health's founder and CEO, said the company will use the funds to support existing customers. 

"Our customers really have the middle of the market. These are large, independent practices, hospitals and smaller health systems. Helping them give or hand off more of the back office to Honey Health," Faustman said. "Today we have five of what we call agents or AI staff members available working across the back office for our customers, and we intend to add a lot more to really build into our vision of handling the entire back office."

Faustman said he has customers who are rapidly trying to give more of this work to AI or the company's AI staff member. 

Additionally, Honey Health is adding more customers to the middle of that market, where Faustman said he is seeing more demand.

"We really want to establish our footprint there as the AI back office for that market," he said. 

The first version of AI in healthcare was about trusting that AI could actually do what people were saying it could do and that it was going to have an impact on organizations, according to Faustman.

"That was the early testing of the water phase. I think as we go into 2026 and beyond what you are going to see is organizations looking for an operational platform rather than narrow point solutions, one they can quickly operationalize and scale," Faustman said.

He said more organizations want to move away from point solutions.

"They are drowning in point solutions, legacy and even AI point solutions. This is also what is helping our momentum. You are seeing organizations wanting to invest in platforms, whether that be for the front office or for certain aspects of the clinical work or patient experience. And certainly the back office," Faustman said.

"They are looking for platforms that can handle multiple pieces of big workflows. I think Honey is really well-positioned for that."